Active Shortage

KENALOG-10 INJECTION

BRISTOL-MYERS SQUIBB CANADA

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of KENALOG-10 INJECTION in Canada?

Yes. KENALOG-10 INJECTION 10MG has an active shortage reported to Health Canada (last updated October 30, 2026).

Why is KENALOG-10 INJECTION not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will KENALOG-10 INJECTION be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusActive Shortage

Same-ingredient products on file6 products · 0 same form & route

Affected strength10MG

Report last updated2026-10-30

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

TRIADERM CRM 0.1%

TARO PHARMACEUTICALS INC

0.1% · DIN 00716960

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

ORACORT

TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.

0.1% · DIN 01964054

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

ARISTOCORT C

BAUSCH HEALTH, CANADA INC.

0.5% · DIN 02194066

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

ARISTOCORT R

BAUSCH HEALTH, CANADA INC.

0.1% · DIN 02194031

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

NASACORT AQ

SANOFI CONSUMER HEALTH INC

55MCG · DIN 02213834

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

NASACORT ALLERGY 24HR

SANOFI CONSUMER HEALTH INC

55MCG · DIN 02417510

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

01999761

Strength

10MG

Dosage Form

SUSPENSION

Route

INTRASYNOVIAL INTRADERMAL INTRABURSAL INTRA-ARTICULAR

Active Ingredient

TRIAMCINOLONE ACETONIDE

Tier

Unrated

Last Updated

2026-10-30

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from BRISTOL-MYERS SQUIBB CANADA

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ABRAXANE FOR INJECTABLE SUSPENSION

100MG · DIN 02281066

0.5MG · DIN 02282224

120000000CELLS · DIN 02527138

10MG · DIN 02532565

15MG · DIN 02532573

5MG · DIN 02532557

2.5MG · DIN 02532549

100MG · DIN 00360414

CEFZIL POWDER FOR ORAL SUSPENSION-125MG/5ML

125MG · DIN 02163675

CEFZIL POWDER FOR ORAL SUSPENSION-250 MG/ 5 ML

250MG · DIN 02163683

CEFZIL TABLETS - 250MG

250MG · DIN 02163659

CEFZIL TABLETS - 500MG

500MG · DIN 02163667